66 related articles for article (PubMed ID: 34228359)
1. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation.
Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G
J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
3. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
[TBL] [Abstract][Full Text] [Related]
4. Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
Yan C; Yang Q; Gong Z
Neoplasia; 2018 May; 20(5):533-542. PubMed ID: 29649779
[TBL] [Abstract][Full Text] [Related]
5. FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells.
Bates EA; Kipp ZA; Lee WH; Martinez GJ; Weaver L; Becker KN; Pauss SN; Creeden JF; Anspach GB; Helsley RN; Xu M; Bruno MEC; Starr ME; Hinds TD
J Biol Chem; 2024 Mar; 300(3):105691. PubMed ID: 38280429
[TBL] [Abstract][Full Text] [Related]
6. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC.
Deng T; Zhao J; Tong Y; Chen Z; He B; Li J; Chen B; Li R; Deng L; Yu H; Zhang B; Zhang T; Shi Z; Gao B; Jiang J; Shan Y; Yu Z; Jin Y; Wang Y; Xia J; Chen G
Oncogene; 2024 Mar; 43(13):944-961. PubMed ID: 38351345
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
Matsuda M; Seki E
Semin Liver Dis; 2020 Aug; 40(3):307-320. PubMed ID: 32242330
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion.
Mao Y; Wu C; Wang X; Zhang F; Qi X; Li X; Li P; Tang B
Commun Biol; 2024 May; 7(1):558. PubMed ID: 38730013
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
[TBL] [Abstract][Full Text] [Related]
11. Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma.
Sun YD; Zhang H; Li YM; Han JJ
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189086. PubMed ID: 38342420
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling.
Lai CY; Yeh KY; Lin CY; Hsieh YW; Lai HH; Chen JR; Hsu CC; Her GM
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668153
[TBL] [Abstract][Full Text] [Related]
13. Friend or foe? The elusive role of hepatic stellate cells in liver cancer.
Cogliati B; Yashaswini CN; Wang S; Sia D; Friedman SL
Nat Rev Gastroenterol Hepatol; 2023 Oct; 20(10):647-661. PubMed ID: 37550577
[TBL] [Abstract][Full Text] [Related]
14. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice.
Lee SH; Park JW; Woo SH; Go DM; Kwon HJ; Jang JJ; Kim DY
Oncotarget; 2016 Dec; 7(52):87219-87231. PubMed ID: 27888617
[TBL] [Abstract][Full Text] [Related]
15. IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway.
Sun D; Li W; Ding D; Tan K; Ding W; Wang Z; Fu S; Hou G; Zhou WP; Gu F
Cell Death Discov; 2024 May; 10(1):230. PubMed ID: 38740736
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of ERK1/2 in cancer-associated hepatic stellate cells suppresses cancer-stromal interaction by regulating extracellular matrix in fibrosis.
Lin Q; Lei D; Zhong T; Zhang Y; Da Q; Chen X; Li X; Liu J; Yan Z
Am J Cancer Res; 2024; 14(3):1015-1032. PubMed ID: 38590418
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development.
Haque A; Sahu V; Lombardo JL; Xiao L; George B; Wolff RA; Morris JS; Rashid A; Kopchick JJ; Kaseb AO; Amin HM
J Hepatocell Carcinoma; 2022; 9():823-837. PubMed ID: 35996397
[TBL] [Abstract][Full Text] [Related]
18. Research progress of periostin and osteoporosis.
Yuan C; Li J
Front Endocrinol (Lausanne); 2024; 15():1356297. PubMed ID: 38487345
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of Stat3 and periostin synergistically protects mice against liver fibrosis.
Xiao H; Niu D; Zhang B
J Hepatol; 2024 May; 80(5):e207-e209. PubMed ID: 38081364
[No Abstract] [Full Text] [Related]
20. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
